Abstract
To clinically evaluate the use of ceria-stabilized zirconia/alumina nanocomposite (Ce-TZP/A) for the frameworks of removable dental prostheses (RDPs). A total of 20 Ce-TZP/A RDPs (10 complete dentures and 10 implant-supported overdentures) were used in 16 patients, and the presence/absence of complications and patient complaints were evaluated. The survival rate of the RDPs during a mean follow-up period of 55.6 months was 100%, with no major complications. The patients experienced uneventful courses functionally and esthetically. In addition, there was no incidence of breakage or repair related to the Ce-TZP/A frameworks.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
